phrykt

Takeda Pharmaceutical Co Ltd (TAK): who owns it and who trades it

As of Nov 16, 2026, TAK insiders reported 22 open-market sales worth $15.2M and no purchases in the last 12 months, with 16% of the sale value made under pre-set 10b5-1 plans. The largest seller was Andrew Stewart Plump (President), with $5.3M. 8 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Takeda Pharmaceutical

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns TAK

377 funds and institutions reported TAK shares worth $1.7B at the end of Q2 2026. The largest holder is Capital Research Global Investors with $309M.

10 largest owners, by value

Capital Research Global Investors$309M
FMR LLC (Fidelity)$154M
Morgan Stanley$112M
Adage Capital Partners Gp, L.l.c.$97M
Goldman Sachs Group Inc$82.2M
Brandes Investment Partners, LP$72.8M
Arrowstreet Capital, Limited Partnership$59.8M
BlackRock, Inc.$59.1M
Renaissance Technologies LLC$41.2M
Qube Research & Technologies Ltd$35.4M

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Capital Research Global Investors19.30M–$309M+1%
FMR LLC (Fidelity)9.60M–$154M+35%
Morgan Stanley6.99M–$112M+8%
Adage Capital Partners Gp, L.l.c.6.05M–$97M-6%
Goldman Sachs Group Inc5.13M–$82.2M-9%
Brandes Investment Partners, LP4.54M–$72.8M+2%
Arrowstreet Capital, Limited Partnership3.73M–$59.8M+20%
BlackRock, Inc.3.69M–$59.1M+16%
Renaissance Technologies LLC2.57M–$41.2M-14%
Qube Research & Technologies Ltd2.21M–$35.4M–
First Trust Advisors LP2.11M–$33.9M+7%
D. E. Shaw & Co., Inc.2.05M–$32.9M-21%
Managed Asset Portfolios, LLC1.82M–$29.2M+1%
Northern Trust Corp1.74M–$27.9M-11%
Van Eck Associates Corp1.67M–$26.8M-26%
Envestnet Asset Management Inc1.60M–$25.6M+13%
AQR Capital Management LLC1.53M–$24.5M+71%
Quantinno Capital Management LP1.40M–$22.5M+9%
Wells Fargo & Company1.15M–$18.4M+1%
Millennium Management LLC1.05M–$16.8M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, TAK insiders reported $0 of open-market purchases and $15.2M of sales. 16% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$15.2M
22 trades, 13 people
Sales under a 10b5-1 plan
16%
Share of sale value
Latest trade
Nov 4, 2026
Filed Nov 5, 2026

Purchases and sales by month

$10.3M$10.3MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 4, 2026Giles Richard PlatfordPresidentSale55,617$20.90$1.2MForm 4
Nov 2, 2026Teresa Marie BitettiPresidentSale46,609$20.89$974KForm 4
Sep 14, 2026Lauren Rusckowski DupreyChief Transformation OffSale34,535$18.54$640KForm 4
Sep 2, 2026Andrew Stewart PlumpPresidentSale plan116,191$18.49$2.1MForm 4
Aug 19, 2026Andrew Stewart PlumpPresidentSale plan19,651$18.49$363KForm 4
Aug 18, 2026Nicola Deidre Petal GreenwayChief Human Resources OfSale12,980$18.11$235KForm 4
Aug 11, 2026Elaine Mary ShannonPres.Sale20,363$17.55$357KForm 4
Aug 10, 2026Awny Samaan Botros FarajallahChief Medical OfficerSale14,006$17.10$240KForm 4
Aug 10, 2026Ramy Riad Ahmed IbrahimPresidentSale7,277$17.10$124KForm 4
Aug 10, 2026Rhonda Janice PachecoPresidentSale16,901$17.10$289KForm 4
Aug 10, 2026Lauren Rusckowski DupreyChief Transformation OffSale47,586$17.10$814KForm 4
Aug 10, 2026Andrew Stewart PlumpPresidentSale165,393$17.10$2.8MForm 4
Aug 10, 2026Agosti Marcello PignagnoliHeadSale22,957$17.10$393KForm 4
Aug 10, 2026Teresa Marie BitettiPresidentSale50,012$17.10$855KForm 4
Aug 10, 2026Elaine Mary ShannonPres.Sale3,978$17.10$68KForm 4
Aug 10, 2026Gabriele RicciChief Data & Tech. OfficSale25,088$17.10$429KForm 4
Aug 10, 2026Nicola Deidre Petal GreenwayChief Human Resources OfSale6,774$17.10$116KForm 4
Aug 10, 2026Julie So-Young KimCEOSale89,090$17.10$1.5MForm 4
Aug 10, 2026Giles Richard PlatfordPresidentSale31,083$17.10$532KForm 4
Aug 10, 2026Natalie Anne Marie FurneyGlobal General CounselSale30,868$17.10$528KForm 4
Aug 10, 2026Nicola Deidre Petal GreenwayChief Human Resources OfSale33,628$17.51$589KForm 4
Aug 10, 2026Nicola Deidre Petal GreenwayChief Human Resources OfSale975$17.50$17.1KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Andrew Stewart PlumpPresident, R&D, Director–$5.3MSep 2, 2026
Teresa Marie BitettiPresident, OBU–$1.8MNov 2, 2026
Giles Richard PlatfordPresident, IBU–$1.7MNov 4, 2026
Julie So-Young KimPresident and CEO, Director–$1.5MAug 10, 2026
Lauren Rusckowski DupreyChief Transformation Officer–$1.5MSep 14, 2026
Nicola Deidre Petal GreenwayChief Human Resources Officer–$957KAug 18, 2026
Natalie Anne Marie FurneyGlobal General Counsel–$528KAug 10, 2026
Gabriele RicciChief Data & Tech. Officer–$429KAug 10, 2026
Elaine Mary ShannonPres., Global Supply & Quality–$425KAug 11, 2026
Agosti Marcello PignagnoliHead, Strat. & Port. Dev–$393KAug 10, 2026
Rhonda Janice PachecoPresident, U.S. Business Unit–$289KAug 10, 2026
Awny Samaan Botros FarajallahChief Medical Officer–$240KAug 10, 2026
Ramy Riad Ahmed IbrahimPresident, PDT BU–$124KAug 10, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

TAK short interest

3.07M TAK shares are sold short. Over the last 12 reports the number of shares short went down 21%.

As of Oct 30, 2026, 3.07M TAK shares were sold short, down 6.8% from the report before. At the average daily volume of 2.99M shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short

3.07MMay 15Oct 305.74M

Days to cover

1.0May 15Oct 302.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20263.07M–-7%2.99M1.0
Oct 15, 20263.29M–+13%3.00M1.1
Sep 30, 20262.92M–-31%2.45M1.2
Sep 15, 20264.20M–+3%2.16M1.9
Aug 31, 20264.09M–+37%2.22M1.8
Aug 14, 20262.99M–+4%3.61M1.0
Jul 31, 20262.87M–-25%4.53M1.0
Jul 15, 20263.82M–-27%2.97M1.3
Jun 30, 20265.26M–-2%2.79M1.9
Jun 15, 20265.37M–+10%3.28M1.6
May 29, 20264.88M–+26%3.01M1.6
May 15, 20263.88M–-22%3.49M1.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Famous investors that hold TAK

8 of the 50 well-known investors we track reported holding TAK in their latest 13F filing. The largest position is Jim Simons's, worth $41.7M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 20262.29M$41.7M0.1%-11%
Israel Englander · Millennium ManagementQ3 20261.33M$24.2M0.0%+27%
Ken Griffin · Citadel AdvisorsQ3 2026798,062$14.5M0.0%+375%
Paul Tudor Jones · Tudor Investment CorpQ3 2026438,448$8M0.0%+338%
Steve Cohen · Point72 Asset ManagementQ3 2026423,379$7.7M0.0%+445%
Ken Fisher · Fisher Asset ManagementQ3 202686,978$1.6M0.0%New
Richard Pzena · Pzena Investment ManagementQ3 202645,310$824K0.0%+20%
Ray Dalio · Bridgewater AssociatesQ3 202621,276$387K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Takeda Pharmaceutical Co Ltd (TAK) stock

Who owns the most TAK stock?

The largest reported owner of Takeda Pharmaceutical Co Ltd (TAK) is Capital Research Global Investors. In total, 377 funds and institutions reported holding TAK at the end of Q2 2026. See the largest owners.

Are TAK insiders buying or selling?

In the last 12 months, TAK insiders reported no open-market purchases and 22 sales worth $15.2M. The latest trade was on Nov 4, 2026. See every trade.

What is the short interest in TAK?

As of Oct 30, 2026, 3.07M TAK shares were sold short, down 6.8% from the report before. At the average daily volume of 2.99M shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Which famous investors hold TAK?

8 of the 50 well-known investors we track reported TAK in their latest 13F filing, including Jim Simons, Israel Englander, Ken Griffin. The largest position is worth $41.7M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.